Dermapharm Holding SE (ETR:DMP)
46.20
+0.55 (1.20%)
Apr 17, 2026, 5:35 PM CET
Dermapharm Holding SE Revenue
In the year 2025, Dermapharm Holding SE had annual revenue of 1.18B EUR, down -1.43%. Dermapharm Holding SE had revenue of 299.91M in the quarter ending December 31, 2025, with 1.44% growth.
Revenue
1.18B
Revenue Growth
-1.43%
P/S Ratio
2.11
Revenue / Employee
326.42K
Employees
3,551
Market Cap
2.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.18B | -17.07M | -1.43% |
| Dec 31, 2024 | 1.20B | 44.72M | 3.89% |
| Dec 31, 2023 | 1.15B | 110.19M | 10.59% |
| Dec 31, 2022 | 1.04B | 80.46M | 8.38% |
| Dec 31, 2021 | 960.09M | 151.78M | 18.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.58B |
| Siemens Healthineers AG | 23.30B |
| Fresenius SE & Co. KGaA | 22.87B |
| Merck KGaA | 21.10B |
| Drägerwerk AG & Co. KGaA | 3.48B |
| Redcare Pharmacy NV | 2.94B |
| Fielmann Group AG | 2.42B |
| Carl Zeiss Meditec AG | 2.20B |
Dermapharm Holding SE News
- 12 days ago - EQS-PVR: Dermapharm Holding SE: Publication of acquisition or disposal in respect of own shares according Sec. 40 para. 1 sent. 2 WpHG - Wallstreet:Online
- 4 weeks ago - EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online